Jesus E. Juarez (@jesusj_md) 's Twitter Profile
Jesus E. Juarez

@jesusj_md

Rising chief resident in #RadiationOncology @uclahealth interested in #ProstateCancerResearch #Theranostics

ID: 50780394

calendar_today25-06-2009 21:44:19

431 Tweet

602 Followers

1,1K Following

Trudy Wu, MD (@trudywumd) 's Twitter Profile Photo

My dear friend @DrNoMDCMD and I have started a mock orals based podcast! We are really excited to share and grow ATB! #radiationoncology #medical #MedEd

Trudy Wu, MD (@trudywumd) 's Twitter Profile Photo

Truly inspirational to hear from Dan Golden MD MHPE about the future of rad onc education! Grateful to have leaders like you in our field. It was the best way to celebrate Thank a Resident Day, in addition to a delightful brunch with Michael Steinberg MD and Ann Raldow, MD, MPH ☺️

Truly inspirational to hear from <a href="/d_golden/">Dan Golden MD MHPE</a> about the future of rad onc education! Grateful to have leaders like you in our field. It was the best way to celebrate Thank a Resident Day, in addition to a delightful brunch with <a href="/MSteinbergMD/">Michael Steinberg MD</a> and <a href="/AnnRaldow_MD/">Ann Raldow, MD, MPH</a> ☺️
Idalid "Ivy" Franco MD MPH (@ivyradoncmd) 's Twitter Profile Photo

National Latino Physician Day #ASTRO24 In the U.S. Latino/a/e/x are greater than 19% of population but 6% of physicians. In #RadOnc we are 5.6% of residents & 2% of practicing physicians. #RepresentationMatters #SiSePuede #NationalLatinoPhysicianDay #NLPD ASTRO ARRO

National Latino Physician Day #ASTRO24 

In the U.S. Latino/a/e/x are greater than 19% of population but 6% of physicians.

In #RadOnc we are 5.6% of residents &amp; 2% of practicing physicians.

#RepresentationMatters #SiSePuede #NationalLatinoPhysicianDay #NLPD <a href="/ASTRO_org/">ASTRO</a> <a href="/ARRO_org/">ARRO</a>
Jesus E. Juarez (@jesusj_md) 's Twitter Profile Photo

Honored to receive a 2025 Genitourinary Cancers Symposium Merit Award at ASCO alongside my chief co-resident, Dr. John Nikitas! Grateful to Conquer Cancer, the ASCO Foundation, collaborators and my mentors for their support Amar Kishan Michael Steinberg MD

Honored to receive a 2025 Genitourinary Cancers Symposium Merit Award at <a href="/ASCO/">ASCO</a> alongside my chief co-resident, Dr. John Nikitas! Grateful to <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a>, collaborators and my mentors for their support <a href="/AmarUKishan/">Amar Kishan</a> <a href="/MSteinbergMD/">Michael Steinberg MD</a>
Bobby Koneru, MD (@konerumd) 's Twitter Profile Photo

It is exciting to witness Radiation Oncology taking on an increasingly pivotal role in the management of metastatic prostate cancer (mCRPC). The recent approval of Pluvicto (Lutetium-177) for use prior to taxane-based chemotherapy marks a significant milestone, paving the way for

It is exciting to witness Radiation Oncology taking on an increasingly pivotal role in the management of metastatic prostate cancer (mCRPC). The recent approval of Pluvicto (Lutetium-177) for use prior to taxane-based chemotherapy marks a significant milestone, paving the way for
Jesus E. Juarez (@jesusj_md) 's Twitter Profile Photo

Never imagined we’d be navigating diapers, nap schedules, and baby milestones at the same time as my co-residents. It’s been incredible to share this season of life together.😄 #WorkFam #ParenthoodTogether

Never imagined we’d be navigating diapers, nap schedules, and baby milestones at the same time as my co-residents. It’s been incredible to share this season of life together.😄 #WorkFam #ParenthoodTogether
Jesus E. Juarez (@jesusj_md) 's Twitter Profile Photo

🎓✨ Congratulations to our graduating Radiation Oncology seniors! 🎓✨ It has been an incredible honor to train alongside you-your dedication to patient care, passion for advancing our field, and unwavering support for your colleagues have left an indelible mark on all of us.

🎓✨ Congratulations to our graduating Radiation Oncology seniors! 🎓✨

It has been an incredible honor to train alongside you-your dedication to patient care, passion for advancing our field, and unwavering support for your colleagues have left an indelible mark on all of us.
Himanshu Nagar (@himanshunagarmd) 's Twitter Profile Photo

Join us at #ASTRO25 for GU Tumor Board: Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies! 📅Date: September 27, 2025 | 6:15 - 8:45 PM PT 📍Location: San Francisco Marriott Marquis | Nob Hill A-D Program Chair: Ana Kiess, MD, PhD Faculty:

Join us at #ASTRO25 for GU Tumor Board: Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies!
📅Date: September 27, 2025 |  6:15 - 8:45 PM PT
📍Location: San Francisco Marriott Marquis | Nob Hill A-D
Program Chair: Ana Kiess, MD, PhD
Faculty:
the Radiosurgery Society (@the_rss) 's Twitter Profile Photo

We are proud to announce the newly elected RSS Resident Association Executive Committee. We look forward to their leadership & contributions as they strengthen the role of residents in advancing the mission of the RSS. Join the RSS Resident Association at therss.org

We are proud to announce the newly elected RSS Resident Association Executive Committee.  We look forward to their leadership &amp; contributions as they strengthen the role of residents in advancing the mission of the RSS. Join the RSS Resident Association at therss.org
Jeff White (@prjeffwhite) 's Twitter Profile Photo

Proud to be a part of this global initiative. I know first-hand how RT can cure cancer. We speak with one voice about the power of radiation therapy. #WRAD #WorldRTDay

Proud to be a part of this global initiative.  I know first-hand how RT can cure cancer. 

We speak with one voice about the power of radiation therapy. 
#WRAD #WorldRTDay
Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

When my husband died of cancer, I used his life insurance to 1) pay the bills while adrift/grieving and ultimately 2) pay for medical school. Because 🧑🏻‍🎓⚕️is very expensive, I still ended up with >$150k of student loans. Today I was finally able to completely pay off my debt. ✅

When my husband died of cancer, I used his life insurance to 1) pay the bills while adrift/grieving and ultimately 2) pay for medical school.

Because 🧑🏻‍🎓⚕️is very expensive, I still ended up with &gt;$150k of student loans.

Today I was finally able to completely pay off my debt. ✅
UCLA Jonsson Comprehensive Cancer Center (@uclahealthjccc) 's Twitter Profile Photo

Don’t miss Dr. Jesus Juarez Casillas at #ASTRO25 presenting results from the SCIMITAR trial testing SBRT for men at risk of prostate cancer returning after surgery. Learn more: bit.ly/46dcNYh

Don’t miss Dr. Jesus Juarez Casillas at #ASTRO25 presenting results from the SCIMITAR trial testing SBRT for men at risk of prostate cancer returning after surgery.

Learn more: bit.ly/46dcNYh
Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

🔥 LUNAR trial: In oligometastatic hormone-sensitive #ProstateCancer, adding 2 cycles of 177Lu-PSMA 💥 ☢️ before SBRT ⬆️ doubled PFS (18 vs 7 mo, HR 0.32, p<0.001) with minimal added adverse events. 🚀 PSMA-RLT + SBRT = new frontier #ASTRO25 #RadOnc #NuclearMedicine ASTRO

🔥 LUNAR trial: In oligometastatic hormone-sensitive #ProstateCancer, adding 2 cycles of 177Lu-PSMA 💥 ☢️ before SBRT ⬆️ doubled PFS (18 vs 7 mo, HR 0.32, p&lt;0.001) with minimal added adverse events. 
🚀 PSMA-RLT + SBRT = new frontier #ASTRO25 #RadOnc #NuclearMedicine <a href="/ASTRO_org/">ASTRO</a>
Amar Kishan (@amarukishan) 's Twitter Profile Photo

Another almost simultaneous publication with ASTRO , this time in European Urology co-led by Jesus E. Juarez C. who delivered the oral presentation at ASTRO: authors.elsevier.com/a/1lsL514kpm0s… 4-year results of the SCIMITAR trial of SBRT to the prostate fossa . .

Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Our responsibility is to our patients, to ensure they’re well informed & to offer them safe, high quality care using the best available evidence. Media pieces can educate if they offer balanced perspectives rather than cherry-picked data serving a predetermined narrative. 1/2